MIRA INFORM REPORT

 

 

Report Date :

03.03.2011

 

Note : The Correct Name of the company is CHITRA PRECIOUS MECHTECH PRIVATE LIMITED.

 

IDENTIFICATION DETAILS

 

Name :

CHITRA PRECIOUS MECHTECH PRIVATE LIMITED

 

 

Formerly Known as :

CHITRA PHARMA MACHINERY (w.e.f. 22.06.2005) – Partnership

 

CHITRA PHARMA MACHINERY (w.e.f. 2000) – Proprietorship

 

 

Registered Office :

4809/1, Phase IV, G.I.D.C. Near Water Tank, Vatva, Ahmedabad-382442, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

27.09.2010

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Precious 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (29)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 49000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was a proprietory concern established in the year 2000. Later it converted into partnership firm in the year 2005 and later it again converted into private limited company in the year September 2010.

 

Trade relations are reported as fair. Payments are reported to be usually correct.

 

The company can be considered for small to mediocre business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Piyush Tripathi

Designation :

Marketing

Contact No.:

91-9724407766

Date :

23.02.2011

 

 

LOCATIONS

 

Registered Office/ Factory :

4809/1, Phase IV, G.I.D.C. Near Water Tank, Vatva, Ahmedabad-382442, Gujarat, India

Tel. No.:

91-79-25842237

Fax No.:

91-79-25840026

E-Mail :

info@chitrapharmamachine.com

info@chitrapharma.com

Website :

http://www.chitrapharma.com

Area :

20000 sq. ft.

Location :

Owned

 

 

 

 

DIRECTOR

 

AS ON 22.09.2010

 

Name :

Mr. Nishesh Agarwal

Designation :

Director

Date of Birth/Age :

20.08.1982

Address :

B-32, Shaligram 3, Near Prahalad Nagar Garden, Satellite, Ahmedabad – 15, Gujarat, India

Qualification :

B.E.I.T.

 

 

Name

Mrs. Chitra Agarwal

Designations :

Director

Date of Birth / Age :

22.09.1956

Address :

B-32, Shaligram 3, Near Prahalad Nagar Garden, Satellite, Ahmedabad – 15, Gujarat, India

Qualification :

M.A.

 

 

KEY EXECUTIVES

 

Name :

Mr. Piyush Tripathi

Designation :

Marketing Head

 

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 22.09.2010

 

Names of Shareholders

 

No. of Shares

Nishesh Agarwal

 

5000

Chitra Agarwal

 

5000

 

 

 

Total

 

10000

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Precious

 

 

Products :

  • Process Equipments
  • Packaging Machinery

 

 

Terms :

 

Selling :

L/C, Cash (30 days , 60 days)

 

 

Purchasing :

Cash ( 90 days)

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

29 (In office – 17 and in factory 12)

 

 

Bankers :

Axis Bank, Maninagar Branch, Ground Floor, Business square building, Near Krishnabag Char Rasta, Maninagar, Ahmedabad, Gujarat, India

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

M/s K.P. Sompara and Company

Chartered Accountants

Address :

Ahmedabad, Gujarat, India

 

 

Associates/Subsidiaries :

Precious Fabcast Private Limited

Address : Ahmedabad, Gujarat, India

Line of Business : Manufacturer and Exporter of Process and Packaging Machinery.

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs.10/- each

Rs. 5.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

305000

Equity Shares

Rs.10/- each

Rs. 3.050 Millions

 

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

3.752

2.666

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

8.486

5.198

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

12.238

7.864

LOAN FUNDS

 

 

 

1] Secured Loans

 

0.380

3.229

2] Unsecured Loans

 

0.593

0.296

TOTAL BORROWING

 

0.973

3.525

DEFERRED TAX LIABILITIES

 

0.490

0.343

 

 

 

 

TOTAL

 

13.701

11.732

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

3.961

2.966

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

0.000

0.000

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

15.068

13.445

 

Sundry Debtors

 

18.855

12.103

 

Cash & Bank Balances

 

1.469

0.456

 

Other Current Assets

 

0.114

0.052

 

Loans & Advances

 

5.346

3.264

Total Current Assets

 

40.852

29.320

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Other Current Liabilities

 

29.353

18.750

 

Provisions

 

1.759

1.804

Total Current Liabilities

 

31.112

20.554

Net Current Assets

 

9.740

8.766

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

13.701

11.732

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

 

102.163

87.915

 

 

Other Income

 

0.234

0.258

 

 

TOTAL                                     (A)

 

102.397

88.173

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Goods

 

64.796

53.525

 

 

Administrative Expenses

 

19.065

17.014

 

 

Manufacturing Expenses

 

11.282

11.046

 

 

TOTAL                                     (B)

 

95.143

81.585

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

 

7.254

6.588

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

 

1.156

1.311

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

 

6.098

5.277

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

1.508

1.363

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

 

4.590

3.914

 

 

 

 

 

Less

TAX                                                                  (I)

 

1.300

1.140

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

 

3.290

2.774

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

 

5.917

5.589

 

TOTAL EARNINGS

 

5.917

5.589

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

10.78

9.09

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2010

31.03.2009

PAT / Total Income

(%)

 

3.21

3.14

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

4.49

4.45

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

10.24

12.12

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.37

0.49

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

2.62

3.06

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.31

1.42

 

 

LOCAL AGENCY FURTHER INFORMATION

 

As per Website Details :

 

Profile

 

Subject (Previously Chitra Pharma Machinery) has designed its plants with the view to reduce maintenance cost, lower downtime and to achieve high quality. Total solution of processing and mechanized conveying of material - right from the raw material feed to the packing section; to materialize your dreams becomes Precious' responsibility. In order to meet the international requirements, they are developing machines of higher capacities in the field of Chemicals, Minerals, Cement, Spices and other agro products, Tobacco, Ayurvedic Herbs, Pharmaceuticals, Paints, Plastics, Ceramics, etc. People are finding that Precious' systems are advance, economical, qualitative, simple and easy to maintain.

 

Subject (Previously Chitra Pharma Machinery) has one of the best and well balanced teams to design different systems for the automation and hence, to reduce manpower and to improve quality of products. With adage to be Technological leader and force on control and efficient solution to all our cliental requirements, understanding the process requirement and enhancing to its best efficiency and giving satisfactory results to all their clients has made the company what it is.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 45.12

UK Pound

1

Rs. 73.43

Euro

1

Rs. 62.32

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

NO

TOTAL

 

29

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.